JPS5810370B2 - Bifunctional terpenoids - Google Patents
Bifunctional terpenoidsInfo
- Publication number
- JPS5810370B2 JPS5810370B2 JP55002394A JP239480A JPS5810370B2 JP S5810370 B2 JPS5810370 B2 JP S5810370B2 JP 55002394 A JP55002394 A JP 55002394A JP 239480 A JP239480 A JP 239480A JP S5810370 B2 JPS5810370 B2 JP S5810370B2
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- acid
- tetrahydropyranyl
- compound
- oxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003505 terpenes Chemical class 0.000 title claims description 4
- 230000001588 bifunctional effect Effects 0.000 title description 2
- 150000001875 compounds Chemical class 0.000 claims description 37
- -1 2-tetrahydropyranyl group Chemical group 0.000 claims description 6
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 2
- 239000002609 medium Substances 0.000 description 21
- 229920001817 Agar Polymers 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- 125000006239 protecting group Chemical group 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 4
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 206010042220 Stress ulcer Diseases 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 208000000718 duodenal ulcer Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- SZTNDPORQFCVOB-UHFFFAOYSA-N 20-hydroxy-2,6,10,14,18-pentamethylicosa-2,6,10,14,18-pentaenoic acid Chemical compound OCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C(O)=O SZTNDPORQFCVOB-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000006916 nutrient agar Substances 0.000 description 2
- 239000012450 pharmaceutical intermediate Substances 0.000 description 2
- 229920001550 polyprenyl Polymers 0.000 description 2
- 125000001185 polyprenyl group Polymers 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- BBBFYZOJHSYQMW-LGDQNDJISA-N (2s)-2,4-diamino-4-oxobutanoic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC(=O)[C@@H](N)CC(N)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O BBBFYZOJHSYQMW-LGDQNDJISA-N 0.000 description 1
- UQZSVIGPZAULMV-DKWTVANSSA-N (2s)-2,4-diamino-4-oxobutanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.OC(=O)[C@@H](N)CC(N)=O UQZSVIGPZAULMV-DKWTVANSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 241000203809 Actinomycetales Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000003794 Gram staining Methods 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241001446247 uncultured actinomycete Species 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明は次の一般式(I)
〔式中、nは1〜5の整数、Aは水酸基の保護基を示す
。DETAILED DESCRIPTION OF THE INVENTION The present invention is directed to the following general formula (I) [wherein n is an integer of 1 to 5, and A represents a hydroxyl group-protecting group.
〕で表わされる新規な二官能性テルペノイドに関するも
のである。This invention relates to a novel bifunctional terpenoid represented by:
本発明化合物は医薬中間体として有用である。The compounds of the present invention are useful as pharmaceutical intermediates.
すなわち、本発明化合物より保護基を脱離した化合物は
抗潰瘍作用を有する。That is, a compound obtained by removing the protective group from the compound of the present invention has an antiulcer effect.
また、ポリプレニルアルコールは降圧剤などの医薬ある
いは補酵素Qの側鎖原料などの医薬中間体として有用な
化合物である。Further, polyprenyl alcohol is a compound useful as a pharmaceutical intermediate such as a medicine such as an antihypertensive agent or a raw material for the side chain of coenzyme Q.
この化合物は特開昭53.103445にも示されてい
るように、本発明化合物の還元体であるヒドロキシ化合
物より次の炭素鎖伸長反応により合成することができる
。As shown in JP-A-53-103445, this compound can be synthesized from a hydroxy compound, which is a reduced form of the compound of the present invention, by the following carbon chain elongation reaction.
(1,m:整数)したがって本発明化合物はポリプレニ
ルアルコールの合成原料としても有用である。(1, m: integer) Therefore, the compound of the present invention is also useful as a raw material for the synthesis of polyprenyl alcohol.
末端に水酸基(保護基で保護された水酸基)を有する鎖
状テルペノイドにおいて、他の末端を酸化して本発明化
合物を得ることは、化学合成的にはかなり困難である。In a chain terpenoid having a hydroxyl group (a hydroxyl group protected with a protective group) at a terminal, it is quite difficult to obtain the compound of the present invention by oxidizing the other terminal in terms of chemical synthesis.
そこで微生物を用いる方法を検討した結果、ノカルデア
(Nocardia )属に属する菌を用いた微生物酸
化により、これを達成した。Therefore, as a result of investigating methods using microorganisms, this was achieved by microbial oxidation using bacteria belonging to the genus Nocardia.
本発明化合物の製造において用いられるノカルデア属に
属する菌の代表的なものとして(BPM1613、微工
研菌寄第1609号)菌株があげもれる。As a representative example of the bacteria belonging to the genus Nocaldea used in the production of the compounds of the present invention, the strain (BPM1613, Microtechnical Research Institute No. 1609) can be mentioned.
本菌株の菌学的性質は次のとおりである。色の表示は日
本色彩研究所刊行の「色の標準」によった。The mycological properties of this strain are as follows. The color display was based on the ``Color Standard'' published by the Japan Color Research Institute.
A 細胞の形態
本菌株は下記培養性状に示す如(、殆んどの培地で特徴
的なオレンジ乃至ピンクを呈する。A Cell Morphology This strain exhibits a characteristic orange to pink color in most media, as shown in the culture characteristics below.
若い栄養細胞は菌糸状に生育し、まれに分岐が観察され
る。Young vegetative cells grow like hyphae, and branching is rarely observed.
古い培養では、菌糸の断裂が起り桿菌0.4〜0.6X
1.3〜2.4μ)になる。In old cultures, hyphae breakage occurs and the bacilli are 0.4 to 0.6X.
1.3 to 2.4μ).
グラム染色陽性。Positive Gram staining.
鞭毛なし。ツイール・ニールセン法による抗酸性菌染色
によっては染色されない。No flagella. It is not stained by acid-fast bacterial staining using the Zwill-Nielsen method.
気菌糸の着生はみとめられない。No epiphyte of aerial mycelia was observed.
・B 各種培地上の性状
1 シュークロース−硝酸塩寒天培地(30℃)生育微
弱、集落の色ピンク、拡散性色素なし。・B Properties on various media 1 Sucrose-nitrate agar medium (30°C) Growth is weak, colony color pink, no diffusible pigment.
2 グルコース−アスパラギン寒天培地(30℃):生
育なし。2 Glucose-asparagine agar medium (30°C): No growth.
3 グリセリン−アスパラギン寒天培地(30℃):生
育微弱、集落の色ピンク、拡散性色素なし。3 Glycerin-asparagine agar medium (30°C): weak growth, pink colony color, no diffusible pigment.
4 スターチ寒天培地(30℃):生育なし。4 Starch agar medium (30°C): No growth.
5 チロシン寒天培地(30℃):生育微弱、集落の色
グレイイシュホワイト、拡散性色素なし。5 Tyrosine agar medium (30°C): weak growth, colony color grayish white, no diffusible pigment.
6 栄養寒天培地(30℃):生育中程度、集落の色オ
レンジ、拡散性色素なし。6 Nutrient agar medium (30°C): Medium growth, colony color orange, no diffusible pigment.
7 イースト:麦芽寒天培地(30℃):生育良好、集
落の色オレンジ、拡散性色素なし。7 Yeast: Malt agar medium (30°C): Good growth, colony color orange, no diffusible pigment.
8 オートミル寒天培地(30℃):生育中程度、集落
の色オレンジ、拡散性色素なし。8 Oatmil agar medium (30°C): Medium growth, colony color orange, no diffusible pigment.
9 カルシウム−マレイド寒天培地(27℃):生育中
程度、集落の色ピンク。9 Calcium-maleide agar medium (27°C): Medium growth, pink colony color.
10 肉汁寒天斜面(27℃):生育中程度、集落の
色うすいピンク。10 Juicy agar slope (27℃): Medium growth, pale pink color of the village.
11 卵−アルブミン斜面(27℃):生育微弱、集
落の色ホワイト。11 Egg-albumin slope (27℃): Growth is weak, colony color is white.
12 バレイショ切片培地(27℃):生育中程度、
集落の色うすいオレンジ。12 Potato section medium (27°C): medium growth,
The color of the village is pale orange.
13 ニンジン切片培地(27℃):生育中程度、集
落の色うすいピンク。13 Carrot section medium (27°C): Medium growth, pale pink color of colonies.
C生理的性質
■ 生育温度範囲(栄養寒天斜面):20〜42℃
2 ゼラチンの液化:陰性
3 スターチの加水分解:陰性
4 脱脂牛乳の凝固、ペプトン化:陰性
5 リドマスミルク:変化なし
6 メラニン様色素の生成:陰性
7 硝酸塩の還元:陽性
8 L−アラビノース、D−キシロース、D−グルコー
ス、D−フラクトース、シュークロース、D−マンニッ
ト、グリセリン、ラクトース、D−ガラクトース、D−
マンノース、マルトース、トレハロース、テンマンから
の酸、ガスの生成なし。C Physiological properties■ Growth temperature range (nutrient agar slope): 20-42℃ 2 Liquefaction of gelatin: Negative 3 Hydrolysis of starch: Negative 4 Coagulation and peptonization of skim milk: Negative 5 Lidmus milk: No change 6 Melanin-like pigment Production: Negative 7 Reduction of nitrate: Positive 8 L-arabinose, D-xylose, D-glucose, D-fructose, sucrose, D-mannite, glycerin, lactose, D-galactose, D-
No acid or gas production from mannose, maltose, trehalose or Tenman.
9 カタラーゼ試験:陰性
10 インドールの生成:陰性
11 硫化水素の生成:陰性
D 各炭素源の同化性(プリドハム・ゴトリープ寒天培
地上、30℃、7日間)
L−アラビノース(イ)、D−キシロース(−+)、D
−グルコース(ト)、D−フラクトース(ト)、シュー
クロース刊、イノシト−/L−(+)、L−ラムノース
(−)、ラフィノース(−)、D−マンニット((1)
、+:生育中程度、+:生育微弱、−:生育なしまた本
菌株は、新井等の方法(Journal ofGene
ral Applied Microbiology、
9.119(1963) : The Actino
mycetales 、 TheJena Inter
national Symposium onTaxo
nomy、273(1968))に準じてグリセロール
・ケルナーモルトン(GlycerolKel ner
Morton )培地で培養した菌体について赤外線
吸収スペクトルを測定したところノカルデア属に特徴あ
る吸収帯(I:C,E型、■:C型、■:C型、■:D
型)を与えた。9 Catalase test: Negative 10 Indole production: Negative 11 Hydrogen sulfide production: Negative D Assimilation of each carbon source (on Pridham-Gotliep agar, 30°C, 7 days) L-arabinose (a), D-xylose ( -+), D
-glucose (t), D-fructose (t), sucrose, inosyto-/L-(+), L-rhamnose (-), raffinose (-), D-mannitol ((1)
, +: Medium growth, +: Slight growth, -: No growth.
ral Applied Microbiology,
9.119 (1963): The Actino
mycetales, TheJena Inter
national symposium on taxo
Glycerol Kelner Molton (Glycerol Kelner Molton)
When we measured the infrared absorption spectrum of the bacterial cells cultured in Morton) medium, we found absorption bands characteristic of the Nocaldea genus (I: C, E type, ■: C type, ■: C type, ■: D
type) was given.
上記の諸性質をパージのマニュアル
(Berey’s Manual of Ddterm
inativeBacteriology )第7版又
はワックスマン著The A ctinomycete
s第2巻により検討すると、ノカルデア属に属すること
が判明した。The above properties are described in Berey's Manual of Ddterm.
Inative Bacteriology) 7th edition or The Actinomycete by Waxman
When examined using Volume 2 of S., it was found that it belongs to the genus Nocaldea.
次に本発明化合物の製造法を示す。Next, a method for producing the compound of the present invention will be described.
ノカルデア属に属し、一般式(n)
〔式中、nは1〜5の整数、Aは水酸基の保護基を示す
。It belongs to the genus Nocaldea and has the general formula (n) [where n is an integer of 1 to 5, and A represents a hydroxyl protecting group.
〕で表わされる化合物酸化能を有する菌を一般式(I[
)の化合物を主炭素源とする培地に培養し、培養体から
一般式(I)
〔式中、n、Aは前記の意味を示す。] A bacterium having the ability to oxidize a compound represented by the general formula (I[
) is cultured in a medium containing the compound of formula (I) as the main carbon source, and the cultured product is synthesized by the general formula (I) [where n and A have the above meanings.
〕で表わされる本発明化合物を採取する。The compound of the present invention represented by ] is collected.
一般式(I)、(II)中のAとしては、水酸基の通常
の保護基を用いることができる。As A in the general formulas (I) and (II), a usual protecting group for a hydroxyl group can be used.
例えば、ベンジル基、テトラヒドロピラニル基、メトキ
シメチル基、メトキシエトキシメチル基などがあげられ
る。Examples include benzyl group, tetrahydropyranyl group, methoxymethyl group, and methoxyethoxymethyl group.
本発明に使用するノカルデア属に属する菌としては、一
般式(II)の化合物に対し酸化能を有する菌であれば
いずれも用いることができる。As the bacteria belonging to the genus Nocaldea used in the present invention, any bacteria can be used as long as it has the ability to oxidize the compound of general formula (II).
このような菌の例として前記の(BPM1613、微工
研菌寄第1609号)菌株があげられる。An example of such a bacterium is the above-mentioned strain (BPM1613, Microtechnical Research Institute No. 1609).
培養方法について具体的に述べると、培養源としては、
主炭素源である一般式(n)の化合物以外は通常使用さ
れるものを用いることができる。Specifically speaking about the culture method, the culture source is:
Other than the compound of general formula (n) which is the main carbon source, commonly used compounds can be used.
窒素源としては、硝酸カリウム、硝酸ナトリウム、硝酸
アンモニウムなどの硝酸塩、塩化アンモニウム、燐酸ア
ンモニウムなどのアンモニウム塩、アンモニア、尿素な
どがあげられる。Examples of nitrogen sources include nitrates such as potassium nitrate, sodium nitrate, and ammonium nitrate, ammonium salts such as ammonium chloride and ammonium phosphate, ammonia, and urea.
また、必要に応じて無機塩として燐酸カリウム、燐酸ナ
トリウム、硫酸マグネシウム、硫酸鉄、硫酸マンガンな
どを、また有機栄養源としてビタミン類、アミノ酸類ま
たはこれらを含有する酵母エキス、コーンスチープリカ
ー、麦芽汁などを添加する。In addition, as necessary, inorganic salts such as potassium phosphate, sodium phosphate, magnesium sulfate, iron sulfate, manganese sulfate, etc. may be added, and organic nutritional sources such as vitamins, amino acids, or yeast extract containing these, corn steep liquor, and wort may be added. etc. are added.
培地のpHは通常7〜10のアルカリ側が良好である。The pH of the medium is usually good on the alkaline side of 7 to 10.
培養温度は20〜40℃で、3〜5日間通気攪拌培養等
の好気的条件下で培養を行なうことができる。The culture temperature is 20 to 40°C, and the culture can be carried out under aerobic conditions such as aerated agitation culture for 3 to 5 days.
培養終了後、培養体を有機溶媒抽出することによって本
発明化合物を採取することができる。After completion of the culture, the compound of the present invention can be collected by extracting the culture with an organic solvent.
抽出溶媒としては、エチルエーテル、ベンゼン、クロロ
ホルムなどが用いられる。Ethyl ether, benzene, chloroform, etc. are used as the extraction solvent.
本発明化合物はシリカゲルのカラムクロマトグラフィー
により分離精製することができる。The compound of the present invention can be separated and purified by silica gel column chromatography.
未反応の原料は上記抽出操作、カラムクロマトグラフィ
ーにより回収することができ(回収率約80〜90%)
、これは再度原料として使用することができる。Unreacted raw materials can be recovered by the above extraction operation and column chromatography (recovery rate of about 80-90%).
, which can be used as raw material again.
次に実施例、実験例を示し、本発明を更に詳しく説明す
る。Next, the present invention will be explained in more detail by showing Examples and Experimental Examples.
実験例 1
原料化合物の製造
(1)テトラヒドロピラニルエーテル
3・7・11・15−テトラメチル−2・6・10・1
4−へキサデカテトラエン−1−オール15gとパラト
ルエンスルホン酸1.5gを塩化メチレンに溶解し、攪
拌下、2・3−ジヒドロピラン8.7gを0〜5℃にて
30分間で滴下した。Experimental example 1 Production of raw material compound (1) Tetrahydropyranyl ether 3.7.11.15-tetramethyl-2.6.10.1
15 g of 4-hexadecatetraen-1-ol and 1.5 g of para-toluenesulfonic acid were dissolved in methylene chloride, and 8.7 g of 2,3-dihydropyran was added dropwise over 30 minutes at 0 to 5°C while stirring. did.
30分間0〜5℃にて攪拌後、分液ロートに移し、炭酸
ナトリウム水溶液で洗った。After stirring at 0 to 5° C. for 30 minutes, the mixture was transferred to a separating funnel and washed with an aqueous sodium carbonate solution.
溶液を濃縮し、濃縮物をシリカゲルのカラムクロマトグ
ラフィーにより精製し、■−(2−テトラヒドロピラニ
ル)オキシ−3・7・11・15−テトラメチル−2・
6・10・14−へキサデカテトラエン13グ(収率6
8%)を得た。The solution was concentrated, and the concentrate was purified by silica gel column chromatography to obtain ■-(2-tetrahydropyranyl)oxy-3,7,11,15-tetramethyl-2.
13 g of 6,10,14-hexadecatetraene (yield: 6
8%).
他のテトラヒドロピラニルエーテルも上記と同様な方法
により得た。Other tetrahydropyranyl ethers were also obtained by the same method as above.
(2)ベンジルエーテル
3・7・11・15−テトラメチル−2・6・10・1
4−へキサデカテトラエン−1−オール: 15グと細
く(たいた水酸化カリウム6.0gをベンジルクロライ
ド100m1に加え、攪拌下、2時間還流した。(2) Benzyl ether 3,7,11,15-tetramethyl-2,6,10,1
4-Hexadecatetraen-1-ol: 6.0 g of potassium hydroxide, which had been reduced to 15 g, was added to 100 ml of benzyl chloride, and the mixture was refluxed for 2 hours with stirring.
冷却後、ヘキサン11を加え、水洗後、濃縮した。After cooling, hexane 11 was added, washed with water, and concentrated.
濃縮物をシリカゲルのカラムクロマトグラフィーにより
精製し、1−ベンジルオキシ−3・7・11・15−テ
トラメチル−2・6・10・14−へキサデカテトラエ
ン12t(収率61%)を得た。The concentrate was purified by silica gel column chromatography to obtain 12t of 1-benzyloxy-3,7,11,15-tetramethyl-2,6,10,14-hexadecatetraene (yield: 61%). Ta.
他のベンジルエーテルも上記と同様な方法により得た。Other benzyl ethers were also obtained in the same manner as above.
実施例1の化合物1%、NH4N030.25%、KH
2PO40,15%、Na2HPO40,15%、Mg
SO4・7H200,05%、FeSO4・7H20o
、ooi%、CaCl2・2H200,001%、酵母
エキス0.002%の組成を有する培地5’0m1(p
H7,2)に、予め同培地(但し、実験例1の化合物の
代りにノルマルパラフィン0.5%)で30℃、2日間
振盪培養して得られたノカルデア属に属する(BPMI
613、微工研菌寄第1609号)菌株の種培養液を8
%(容量)の割合で植菌し、これを500m1容の肩付
フラスコで30℃、5日間振盪培養を行った。Compound of Example 1 1%, NH4N030.25%, KH
2PO40.15%, Na2HPO40.15%, Mg
SO4・7H200,05%, FeSO4・7H20o
, ooi%, CaCl2.2H200,001%, and yeast extract 0.002%.
H7,2), belonging to the genus Nocaldea (BPMI
613, Microtechnical Research Institute No. 1609) Seed culture solution of 8 strains.
% (volume), and cultured with shaking at 30° C. for 5 days in a 500 ml flask with a shoulder.
培養終了後、培養体を硫酸酸性(pH2)下にエチルエ
ーテルで抽出した。After the cultivation was completed, the culture was extracted with ethyl ether under acidic sulfuric acid (pH 2).
溶媒を留去し、残渣をシリカゲルのカラムクロマトグラ
フィーにより精製した。The solvent was distilled off, and the residue was purified by column chromatography on silica gel.
展開溶媒としてヘキサンおよびエチルエーテルを用いた
。Hexane and ethyl ether were used as developing solvents.
得られた化合物を次の表2に示す。The obtained compounds are shown in Table 2 below.
なお、一部の化合物をメチルエステルとしてNMRを測
定した。Note that NMR was measured using some of the compounds as methyl esters.
実験例 2
最終化合物の製造(保護基の脱離)
■ テトラヒドロピラニルエーテル
パラトルエンスルホン酸2.35fにヒリシン6mlを
加え、室温で20分間攪拌した。Experimental Example 2 Production of final compound (removal of protecting group) 6 ml of hiricine was added to 2.35 f of tetrahydropyranyl ether p-toluenesulfonic acid, and the mixture was stirred at room temperature for 20 minutes.
溶媒を留去し、残渣をアセトンで洗った後、水に溶解(
3,15mg/ml) した。After evaporating the solvent and washing the residue with acetone, it was dissolved in water (
3.15 mg/ml).
前記(a)で得た2O−(2−テトラヒドロピラニル)
オキシ−2・6・10・14・18−ペンタメチル−2
・6・10・14・18−エイコサペンタエノイツクア
シッド100mgに上記水溶液4rulを加え、55℃
で3時間攪拌した。2O-(2-tetrahydropyranyl) obtained in the above (a)
Oxy-2, 6, 10, 14, 18-pentamethyl-2
・Add 4 rul of the above aqueous solution to 100 mg of 6, 10, 14, 18-eicosapentaenoic acid, and heat at 55°C.
The mixture was stirred for 3 hours.
冷却後、ニーチルエーテル50m1で抽出し、溶媒を留
去して20−ハイドロキシ−2・6・10・14・18
−ペンタメチル−2・6・10・14・18−エイコサ
ペンタエノイツクアシツド82〜を得た。After cooling, extraction was performed with 50 ml of nityl ether, and the solvent was distilled off to give 20-hydroxy-2, 6, 10, 14, 18
-Pentamethyl-2,6,10,14,18-eicosapentaenoic acid 82~ was obtained.
前駆a)で得た他のテトラヒドロピラニルエーテルも本
方法と同様にして保護基を脱離した。The protecting groups of other tetrahydropyranyl ethers obtained in the precursor a) were removed in the same manner as in this method.
■ ベンジルエーテル
エチルアミン1501rLlに、−78℃窒素気流下に
て、金属リチウムワイヤー(1%ナトリウム含有)1.
7′iIを小片に切って少量ずつ加えた。■Metal lithium wire (containing 1% sodium) 1.
7'iI was cut into small pieces and added in small portions.
−20℃まで温度をあげてリチウムを完全に溶解した後
、再び一78℃に冷却した。After raising the temperature to -20°C to completely dissolve the lithium, it was cooled again to -78°C.
前記(a)で得た16−ベンジルオキシ−2・6・10
・14−テトラメチル−2・6・10・14−ヘキサデ
力テトラエノイックアシッド5vをテトラヒドロンラン
5omlに溶解し、これを上記リチウム溶液に30分間
で滴下した。16-benzyloxy-2,6,10 obtained in the above (a)
- 5v of 14-tetramethyl-2,6,10,14-hexadelic acid was dissolved in 5oml of tetrahydrone, and this was added dropwise to the above lithium solution over 30 minutes.
30分間攪拌した後、溶液に1・3−ブタジェンを溶液
の色(青色)が退色するまで吹きこんだ。After stirring for 30 minutes, 1,3-butadiene was bubbled into the solution until the color (blue) of the solution faded.
得られた黄色の溶液に、色が退色するまでメタノールを
加え、その後、除々に室温にもどした。Methanol was added to the resulting yellow solution until the color faded, and then the temperature was gradually warmed to room temperature.
生成した固形物を沢取し、これを水に溶解した。A lot of the generated solid was collected and dissolved in water.
水冷下、水溶液にIN塩酸を加えて弱酸性とした後、ヘ
キサンで抽出した。Under water cooling, IN hydrochloric acid was added to the aqueous solution to make it weakly acidic, and then extracted with hexane.
抽出液を水、飽和食塩水で順次洗った後、硫酸マグネシ
ウムを加えて乾燥した。The extract was washed successively with water and saturated brine, and then dried by adding magnesium sulfate.
溶液を濃縮し、濃縮物をシリカゲルのカラムクロマトグ
ラフィーで精製して、16−ヒドロキシ−2・6・10
・14−テトラメチル−2・6・10・14−へキサデ
カテトラエノイツクアシツド3.3グを得た。The solution was concentrated, and the concentrate was purified by column chromatography on silica gel to obtain 16-hydroxy-2.6.10
- 3.3 g of 14-tetramethyl-2,6,10,14-hexadecatetraenoic acid was obtained.
前言αa)で得た他のベンジルエーテルも本方法と同様
にして保護基を脱離した。The protecting groups of other benzyl ethers obtained in the above αa) were removed in the same manner as in this method.
得られた化合物を次の表3に示す。The obtained compounds are shown in Table 3 below.
表中、収率の項の*印は上記■のベンジルエーテルの保
護基膜離反の収率を示し、無印は上記■のテトラヒドロ
ピラニルエーテルの保護基脱離反応の収率を示す。In the table, the * mark in the yield section indicates the yield of the protective film removal reaction of the benzyl ether in (1) above, and the unmarked mark indicates the yield of the protective group removal reaction of the tetrahydropyranyl ether in (2) above.
上記で得られた最終化合物は次に示すように、抗潰瘍作
用を有す。The final compound obtained above has anti-ulcer activity as shown below.
寒冷拘束ストレス潰瘍に対する効果
SD系ラット(雌、体重約1701.8〜10週令)を
試験動物に用い、Levineの方法〔Proc、 S
oc、 Exptl 、BioloMed、 124巻
、1221頁(1967年)〕に準じて、寒冷拘束スト
レス潰瘍発生に対する試験化合物の抑制効果を測定した
。Effect on cold restraint stress ulcer SD rats (female, body weight approximately 1701.8 to 10 weeks old) were used as test animals, and Levine's method [Proc, S
oc, Exptl, BioloMed, Vol. 124, p. 1221 (1967)], the inhibitory effect of the test compound on the development of cold restraint stress ulcers was measured.
試験化合物として次のものを選んだ。12−ヒドロキシ
−2・6・10−)リメチル−2・6・10−ドデカト
リエノイックアシッド(化合物A)
16−ヒドロキシ−2・6・10・14−テトラメチル
−2・6・10・14−ヘキサデ力テトラエノイツクア
シツド(化合物B)
20−ヒドロキシ−2・6・10・14・18−ペンタ
メチル−2・6・10・14・18−エイコサペンタエ
ノイツクアシツド(化合物C)次表に寒冷拘束ストレス
潰瘍発生抑制率を示す。The following were selected as test compounds. 12-hydroxy-2,6,10-)limethyl-2,6,10-dodecatrienoic acid (compound A) 16-hydroxy-2,6,10,14-tetramethyl-2,6,10,14 -Hexadelic tetraenoic acid (compound B) 20-hydroxy-2,6,10,14,18-pentamethyl-2,6,10,14,18-eicosapentaenoic acid (compound C) The table shows the inhibition rate of cold restraint stress ulcer occurrence.
Claims (1)
。 〕で表わされる二官能性テルペノイド。 2 Aがベンジル基または2−テトラヒドロピラニル基
である特許請求の範囲第1項記載の化合物。 38−(2−テトラヒドロピラニル)オキシ−2・6−
シメチルー2・6−オクタジニノイツクアシツドである
特許請求の範囲第2項記載の化合物。 412−(2−テトラヒドロピラニル)オキシ−2・6
・10−トリメチル−2・6・10−ドデカトリエノイ
ックアシッドである特許請求の範囲第2項記載の化合物
。 512−ベンジルオキソ−2・6・10−トリメチル−
2・6−10−ドデカトリエノイックアシッドである特
許請求の範囲第2項記載の化合物。 $16−(2−テトラヒドロピラニル)オキシ−2・6
・10・14−テトラメチル−2・6・10・14−ヘ
キサデ力テトラエノイツクアシツドである特許請求の範
囲第2項記載の化合物。 716−ベンジルオキシ−2・6・10・14−テトラ
メチル−2・6・10・14−ヘキサデ力テトラエノイ
ツクアシッドである特許請求の範囲第2項記載の化合物
。 82O−(2−テトラヒドロピラニル)オキシ−2・6
・10・14・18−ペンタメチル−2・6・10・1
4・18−エイコサペンタエノイツクアシツドである特
許請求の範囲第2項記載の化合物。 920−ベンジルオキシ−2・6・10・14・18−
ペンタメチル−2・6・10・14・18−エイコサペ
ンタエノイツクアシツドである特許請求の範囲第2項記
載の化合物。 1024−(2−テトラヒドロピラニル)オキシ−2・
6・10・14・18・22−ヘキサメチル−2・6・
10・14・18・22−テトラコサヘキサエノイツク
アシツドである特許請求の範囲第2項記載の化合物。[Scope of Claims] 1 General Formula (I) [In the formula, n is an integer of 1 to 5, and A represents a hydroxyl group-protecting group. ] Difunctional terpenoids. 2. The compound according to claim 1, wherein A is a benzyl group or a 2-tetrahydropyranyl group. 38-(2-tetrahydropyranyl)oxy-2,6-
3. The compound according to claim 2, which is dimethyl-2,6-octazininoacide. 412-(2-tetrahydropyranyl)oxy-2.6
- The compound according to claim 2, which is 10-trimethyl-2,6,10-dodecatrienoic acid. 512-Benzyloxo-2,6,10-trimethyl-
The compound according to claim 2, which is 2,6-10-dodecatrienoic acid. $16-(2-tetrahydropyranyl)oxy-2.6
- The compound according to claim 2, which is 10,14-tetramethyl-2,6,10,14-hexadenate tetraenoic acid. The compound according to claim 2, which is 716-benzyloxy-2,6,10,14-tetramethyl-2,6,10,14-hexadenate tetraenoic acid. 82O-(2-tetrahydropyranyl)oxy-2.6
・10.14.18-pentamethyl-2.6.10.1
The compound according to claim 2, which is 4,18-eicosapentaenoic acid. 920-benzyloxy-2, 6, 10, 14, 18-
The compound according to claim 2, which is pentamethyl-2,6,10,14,18-eicosapentaenoic acid. 1024-(2-tetrahydropyranyl)oxy-2.
6.10.14.18.22-hexamethyl-2.6.
The compound according to claim 2, which is 10,14,18,22-tetracosahexaenoic acid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55002394A JPS5810370B2 (en) | 1980-01-12 | 1980-01-12 | Bifunctional terpenoids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP55002394A JPS5810370B2 (en) | 1980-01-12 | 1980-01-12 | Bifunctional terpenoids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56113734A JPS56113734A (en) | 1981-09-07 |
| JPS5810370B2 true JPS5810370B2 (en) | 1983-02-25 |
Family
ID=11528014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP55002394A Expired JPS5810370B2 (en) | 1980-01-12 | 1980-01-12 | Bifunctional terpenoids |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5810370B2 (en) |
-
1980
- 1980-01-12 JP JP55002394A patent/JPS5810370B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS56113734A (en) | 1981-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4454330A (en) | Two-functional-group-containing terpenoids, processes for the preparation of the same, and anti-ulcer agents containing the same | |
| EP0099692A1 (en) | New furanone derivatives, process for the preparation thereof and use thereof | |
| US4530845A (en) | 1,4-Napthoquinone derivatives and use thereof | |
| JPS5854796B2 (en) | Polyprenylcarboxylic acid derivative and its production method | |
| US4468458A (en) | Two-functional-group-containing terpenoids, processes for the preparation of the same, and anti-ulcer agents containing the same | |
| US4199514A (en) | Compound, frenolicin B which is useful as an antibiotic | |
| JPS5810370B2 (en) | Bifunctional terpenoids | |
| JPH10130269A (en) | Carboline derivative | |
| EP0067938B1 (en) | Polyprenyl sulfone derivatives, process for producing them and their uses | |
| US4456558A (en) | Polyprenyl ketone derivatives | |
| EP0015540B1 (en) | New triazene compound, process for the preparation thereof, and pharmaceutical composition comprising the same | |
| JPH03227971A (en) | Carbazole compound | |
| JPS5810079B2 (en) | Method for producing alcohol derivatives of mixed isoprenoid hydrocarbons using microorganisms | |
| JPS5829078B2 (en) | Production method of coenzyme Q↓1↓0 | |
| JPS6261587A (en) | Production of optically active (r)-hydroxymandelic acid ester intermediate | |
| US3532714A (en) | Antifungal agents | |
| JPS5953838B2 (en) | Method for producing β-hydroxyvaleric acid | |
| EP1431395B1 (en) | 7alpha-hydroxypregn-4-en-3-one-20-carbaldehyde, process for producing the same, and process for producing 7alpha,21-dihydroxy-20-methylpregn-4-en-3-one from the same | |
| JPS5898092A (en) | Production of ml-236-b, (physioligically active substance) | |
| JPS5810078B2 (en) | Novel 2,6,10-trimethyl-1-pentadecanol produced by microorganisms and its production method | |
| JPS5843796A (en) | Preparation of androstane compound by microorganism | |
| JPS59232095A (en) | Production of phenylacetic acid | |
| JPH0329053B2 (en) | ||
| JPS6135788A (en) | Physiologically active substance ss20846a and its preparation | |
| JPH0378108B2 (en) |